Shaun Fleming, MBBS, FRACP, FRCPA, Alfred Hospital, Melbourne, Australia, discusses the use of machine learning to prognosticate patients with acute myeloid leukemia (AML), explaining the benefits of this approach. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.